Healthcare - Biotechnology - NASDAQ - US
$ 0.9752
-8 %
$ 353 M
Market Cap
-1.27
P/E
Price Target
Average
515.26%
Revenue Forecast
Estimate
296.46%
EBIT
Estimate
--4.72%
Net Income
Estimate
28.02%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Lexicon Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for LXRX of $6 , with forecasts ranging from a low of $6 to a high of $6 .
LXRX Lowest Price Target
Wall Street Target
6 USD
515.26%
LXRX Average Price Target
Wall Street Target
6 USD
515.26%
LXRX Highest Price Target
Wall Street Target
6 USD
515.26%
REVENUE FORECAST
Revenue Forecast Chart LXRX
EBIT FORECAST
EBIT Forecast Chart LXRX
NET INCOME FORECAST
Net Income Chart LXRX